Suppr超能文献

采用分子生物学和培养方法对男男性行为者沙眼衣原体的生存能力进行评估。

Viability assessment of Chlamydia trachomatis in men who have sex with men using molecular and culture methods.

作者信息

Rayo Enrique, Pesch Theresa, Onorini Delia, Leonard Cory, Marti Hanna, Schoborg Robert, Low Nicola, Hampel Benjamin, Borel Nicole

机构信息

Chlamydia Group, Institute of Veterinary Pathology, University of Zürich, Zürich, Switzerland.

Chlamydia Group, Institute of Veterinary Pathology, University of Zürich, Zürich, Switzerland.

出版信息

Clin Microbiol Infect. 2025 May;31(5):802-807. doi: 10.1016/j.cmi.2024.12.038. Epub 2025 Jan 8.

Abstract

OBJECTIVES

Chlamydia trachomatis (CT) is the most commonly reported bacterial sexually transmitted infection worldwide. Diagnosis relies on nucleic acid amplification techniques, such as PCR, which does not distinguish between viable pathogens and residual bacterial DNA, leading to potential overdiagnosis and overtreatment. PCR with confirmation of pathogen viability has not been widely explored in the sexually transmitted infection field. We aimed to establish a CT viability PCR (V-PCR) and to apply it to anorectal swabs from men who have sex with men (MSM).

METHODS

We validated a published V-PCR protocol by preparing artificial samples with known ratios of viable and non-viable CT. Mock samples were treated with propidium monoazide (PMAxx) before DNA extraction and quantitative PCR (qPCR) to detect CT. The V-PCR was then applied to CT PCR-positive anorectal swabs from MSM. Viability was expressed as the difference in CT copies between PMAxx untreated and treated samples (ΔLog10 CT/mL). The anorectal samples were inoculated in cell culture for isolation. Genotyping was performed by examining the ompA gene sequence.

RESULTS

Of 236 anorectal swabs, 69 (29.2%) were CT PCR positive, and we obtained V-PCR data from 54. There were 7 of 54 (12.9%), samples with <1% viable CT (>2.52 ΔLog10 CT/mL) 4 of 54 (7.4%) samples with 1% to 10% viable CT (1.59-2.52), 16 of 54 (29.6%) with 10.01% to 50% viable CT (0.86-1.59) and 27 of 54 (50.0%) with 50.01% to 100% viable CT (<0.35-0.86). CT was isolated successfully from 39 of 69 (56.5%) samples in cell culture. Genotypes based on ompA were obtained for 62 of 69 (89.9%) samples: G (n = 15/62), D/Da (n = 15/62), J (n = 15/62), E (n = 11/62), L1 (n = 4/62), and L2 (n = 2).

DISCUSSION

We successfully implemented a viability test based on PCR, which can distinguish, detect and quantify viable CT in anorectal swabs from MSM. Rapid, reliable assessment of CT viability could help to improve antimicrobial stewardship.

摘要

目的

沙眼衣原体(CT)是全球报告最多的细菌性性传播感染病原体。诊断依赖于核酸扩增技术,如PCR,但该技术无法区分存活病原体与残留细菌DNA,可能导致过度诊断和过度治疗。在性传播感染领域,尚未广泛探索用于确认病原体存活能力的PCR技术。我们旨在建立一种CT存活能力PCR(V-PCR),并将其应用于男男性行为者(MSM)的直肠拭子检测。

方法

我们通过制备已知存活和非存活CT比例的人工样本,验证了一种已发表的V-PCR方案。模拟样本在DNA提取和定量PCR(qPCR)检测CT前,先用单叠氮化丙锭(PMAxx)处理。然后将V-PCR应用于MSM的CT PCR阳性直肠拭子。存活能力通过PMAxx处理和未处理样本之间CT拷贝数的差异表示(ΔLog10 CT/mL)。将直肠样本接种于细胞培养物中进行分离。通过检测ompA基因序列进行基因分型。

结果

在236份直肠拭子中,69份(29.2%)CT PCR呈阳性,我们从54份样本中获得了V-PCR数据。54份样本中有7份(12.9%)存活CT<1%(>2.52 ΔLog10 CT/mL),4份(7.4%)存活CT为1%至10%(1.59 - 2.52),16份(29.6%)存活CT为10.01%至50%(0.86 - 1.59),27份(50.0%)存活CT为50.01%至100%(<0.35 - 0.86)。69份样本中有39份(56.5%)在细胞培养中成功分离出CT。69份样本中有62份(89.9%)获得了基于ompA的基因型:G型(n = 15/62)、D/Da型(n = 15/62)、J型(n = 15/62)、E型(n = 11/62)、L1型(n = 4/62)和L2型(n = 2)。

讨论

我们成功实施了一种基于PCR的存活能力检测方法,该方法可以区分、检测和定量MSM直肠拭子中的存活CT。快速、可靠地评估CT存活能力有助于改善抗菌药物管理。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验